Eli Lilly Says Retatrutide Delivers More Than Double Ozempic’s Weight Loss in Late-Stage Diabetes Trial

기사 요약

Lilly’s retatrutide delivered more than double Ozempic’s weight loss in head-to-head diabetes trial